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Understanding the role of the bioactive lipid mediator sphingosine 1-phosphate (S1P)
within the central nervous system has recently gained more and more attention, as it has
been connected to major diseases such as multiple sclerosis and Alzheimer’s disease.
Even though much data about the functions of the five S1P receptors has been collected
for other organ systems, we still lack a complete understanding for their specific roles, in
particular within the brain. Therefore, it was the aim of this study to further elucidate
the role of S1P receptor subtype 3 (S1P3) in vivo and in vitro with a special focus
on the hippocampus. Using an S1P3 knock-out mouse model we applied a range of
behavioral tests, performed expression studies, and whole cell patch clamp recordings
in acute hippocampal slices. We were able to show that S1P3 deficient mice display a
significant spatial working memory deficit within the T-maze test, but not in anxiety related
tests. Furthermore, S1p3mRNA was expressed throughout the hippocampal formation.
Principal neurons in area CA3 lacking S1P3 showed significantly increased interspike
intervals and a significantly decreased input resistance. Upon stimulation with S1P CA3
− −
principal neurons from both wildtype and S1P
/
mice displayed significantly increased3
evoked EPSC amplitudes and decay times, whereas rise times remained unchanged.
These results suggest a specific involvement of S1P3 for the establishment of spatial
working memory and neuronal excitability within the hippocampus.
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INTRODUCTION
The bioactive lysosphingolipid sphingosine 1-phosphate (S1P) plays an important role in the
regulation of various cellular and physiological processes. Two sphingosine kinases (SphK1 and
SphK2) phosphorylate sphingosine to form S1P, which can either act intracellularly or can be
secreted to bind as an extracellular ligand to one of five G protein-coupled receptors (GPCR)
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of the S1P receptor family (S1P1−5) (reviewed in Strub et al.,
2010; Maceyka et al., 2012). The different receptors activate G-
proteins Gi, Gq, and G12/13 and their downstream signaling
pathways. Deregulation of S1P metabolism and signaling occurs
in various diseases as for example Alzheimer’s disease (AD)
and S1P receptors have been discovered as the target of several
recently developed drugs (Couttas et al., 2014; van Echten-
Deckert et al., 2014). One of these, FTY720, which originally has
been launched for the treatment of multiple sclerosis, is currently
also studied within the context of AD and has already been shown
to attenuate beta-amyloid peptide (Aß42)-induced impairment
of spatial learning and memory in rats (Asle-Rousta et al., 2013).
Our lab and others showed that S1P1−3 are expressed in
primary afferent sensory neurons (Zhang et al., 2006; Kays et al.,
2012). Of these S1P1 and S1P3 receptors play a significant role
in regulating nociceptor function (Mair et al., 2011; Camprubí-
Robles et al., 2013). In the central nervous system (CNS) S1P
receptors are found with varying expression levels on different
cell types and both astrocytes and neurons synthesize and
release S1P (reviewed in (Soliven et al., 2011; Choi and Chun,
2013)). In neurons, S1P receptor signaling has been connected
to proliferation, survival, and apoptosis, neurite extension, and
retraction, excitability and neurotransmitter release (Okada et al.,
2009). Furthermore, S1P signaling has been associated with
learning and memory within the hippocampus (Kajimoto et al.,
2007; Kanno et al., 2010; Akahoshi et al., 2011; Kanno and
Nishizaki, 2011; Antonucci et al., 2012; Riganti et al., 2016).
Although there is growing evidence for the importance of S1P
and its receptors for CNS processes, the specific functions of the
individual receptors and their downstream signaling pathways
are not yet fully understood. Therefore, it was the aim of this
study to further elucidate the role of S1P3 in the CNS in vivo
and in vitro using an S1P3 knock-out (S1P
−/−
3 ) mouse model.
We determined the expression of S1P3 within the hippocampal
formation and compared memory- or anxiety-related behavioral
phenotypes in wild-type (WT) and S1P
−/−
3 mice. Furthermore,
using whole cell patch clamp recordings in acute hippocampal
slice preparations we investigated excitability, evoked excitatory
postsynaptic currents (eEPSCs) and ion channel expression in
hippocampal principal neurons lacking S1P3 and compared these
to WT control neurons.
MATERIALS AND METHODS
Ethics Statement
All animal experiments were performed in accordance with
national Austrian law and with permission of the Austrian
Bundesministerium für Wissenschaft und Forschung (BMWF)
(BMWF-66.011/0113-II/3b/2010). Every effort was taken to
minimize the number of animals used in the experiments.
Genetically Modified Mice
WT and S1P
−/−
3 mice were used for the experiments. Global
S1P3 receptor null mutant mice (S1P
−/−
3 ) have been described
previously (Kono et al., 2004). Mice were fully inbred on a
C57BL/6J background and each year the background strain
was refreshed with C57BL/6J mice obtained from Charles River
Laboratories. All behavioral experiments were performed in age-
matched awake, unrestrained, male mice (12–16 weeks old),
which were housed on a 12 h light/dark cycle with free access
to food and water, unless stated otherwise. Experimenters were
blinded to the genotype of the animal. All electrophysiological
and qRT-PCR experiments were performed in mice of either sex
(4–6 weeks old).
qRT-PCR
Hippocampi were obtained as described previously (Spijker,
2011). In brief, mice were anesthetized using Isoflurane
(Forane R©) and decapitated using scissors. Brains were quickly
removed and a fresh dissection of the hippocampus was
performed. Therefore, the cerebellum was removed and the
cortex was opened from the midline. The hippocampi were
dissected and snap-frozen in liquid nitrogen and stored below
−70◦C for<1 month. Total RNA was extracted using peqGOLD
TriFast (PeqLab, Germany). All samples were kept on dry
ice until use and homogenized with plastic pestles in 1 ml
TriFast. After 5min incubation at RT, 200 µl of chloroform were
added. Samples were briefly vortexed, incubated for 10min at
RT and centrifuged for 15min at 4◦C with 12,000 rcf. Fifteen
milligram GlycoBlue
TM
Coprecipitant (Ambion) were added to
the transferred aqueous phase before the addition of 500 µl
of isopropanol. Samples were incubated for 10min at RT and
centrifuged for 10min at 4◦C with 12,000 rcf. The supernatant
was mixed with 1ml of 75% ethanol, briefly vortexed, and
centrifuged for 5min at 4◦C with 12,000 rcf. After discarding the
supernatant, the samples were centrifuged for 2min under the
same conditions. Residual ethanol was discarded and the pellet
was air-dried before dissolving it in DEPC-treated MiliQ water.
RNA quality and quantity was measured using a Nanodrop 2000
(PeqLab/Thermo Scientific).
For reverse transcription, 900 ng of total RNA were mixed
with MuLv reverse transcriptase (2.5 U/µl; Applied Biosystems)
with random hexamer primers (10 ng/µl), RiboLock (2 U/µl),
1x Taq Buffer (all from Thermo Scientific), MgCl2 (5 mM), and
dNTPs (1mM, both Fermentas) in a total volume of 20 µl. After
5min incubation at RT, themix was incubated for 15min at 42◦C,
5min at 99◦C, and 5min at 5◦C using a 2720 Thermal Cycler
(Applied Biosystems).
For quantitative PCR, the RT-product was diluted 1:30 in
autoclaved MilliQ-H2O. In total, 20 µl of reaction volume
consisted of 9 µl diluted cDNA, 1x TaqMan R© Gene Expression
Assay and 1x TaqMan R© Universal Master Mix II (no UNG,
all Applied Biosystems). A list of all assays is provided
in Supplementary Table 1. Reactions were performed in
a MicroAmp Fast Optical 96-Well Reaction Plate (Applied
Biosystems) using the 7500 Fast Real-Time PCR System (Applied
Biosystems) for thermal cycling and real-time fluorescence
measurements. The PCR cycle protocol consisted of 10min at
95◦C, 40 two-step cycles of 15 s each at 95◦C and of 1min at 60◦C.
No-template-controls and No-reverse-transcriptase-controls did
not show amplification. Each sample was run in duplicates.
For the analysis of S1p3, threshold cycle (Cq) values
were recorded as a measure of initial template concentration.
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Threshold was set to 0.2 of the baseline-corrected normalized
reporter fluorescence (1Rn) and baselines were automatically
calculated by the 7500 software (Applied Biosystems). For
samples that did not show amplification curves during the
40 PCR cycles Cq-values were artificially set to 40 for
statistical analysis. Expression levels were calculated as following:
1Cqx,S1p3—geometrical mean (Cqx,Sdha, Cqx,Hprt, Cqx,Tfrc);
11Cqx = 1Cqx—mean 1Cq of all WT samples; S1p3
expression= 2∧-11Cqx.
For the analysis of S1P receptors 1, 2, 4, and 5, and
voltage-gated potassium channels, expression levels and primer
efficiencies were analyzed using LinRegPCR (Version 2015.1)
for hydrolysis probes [window of linearity: 4 points; parameters
for calculation of mean efficiency: exclude no plateau samples,
exclude efficiency outlier samples (>5% from group median),
log-linear phase criterion: strictly continuous log-linear phase]
(Ruijter et al., 2009; Tuomi et al., 2010). See Supplementary
Table 1 for primer efficiencies. Expression levels (N0) were
calculated by N0 = threshold/(Eff_meanCˆq). Target expression
levels were divided by the geometrical mean of Sdha, Hprt and
Tfrc expression levels per sample. All target levels were then
normalized to the mean target expression levels of theWT group.
Outliers were identified using Grubbs’ test (GraphPad Software,
Inc.) and excluded from calculations.
In-situ Hybridization
The protocol was modified from an earlier method from
Obernosterer et al. (2007) and Camprubí-Robles et al. (2013).
Cryostat sections of murine hippocampi were Zamboni-
fixed for 24 h, washed in phosphate buffered saline, digested
with proteinase K (2µg/ml), fixed with 4% PFA, acetylated
(triethanolamine/HCl/acetic anhydride), and incubated with
prehybridisation buffer (Roche). Target mRNAs were hybridized
with 0.34 pmol of specific antisense double digoxigenin (DIG)
labeled mRNA detection probes (S1P3, 5DigN/ACTGATG
AGGAAGGCGATGTAT/3Dig_N) or scrambled probes (Exiqon,
Copenhagen, Denmark) or hybridization buffer as negative
controls overnight at 55◦C (Camprubí-Robles et al., 2013).
Washing with SSC was followed by blocking and incubation
with alkaline phosphatase coupled anti-DIG antiserum.Washing
in PBS followed incubation with secondary antisera for 1 h.
Slides were incubated with BCIP/NBT (Roche) to visualize S1p3
receptor mRNA, washed in PBS and coverslipped in buffered
glycerol. Images were taken using a brightfield microscope
(BX50, Olympus).
Behavioral Testing
T-Maze
Mice were tested in the T-maze rewarded alternation paradigm
in an enclosed maze as described in the protocol by Deacon
and Rawlins (2006). Briefly, during a habituation period of 5
days mice were accustomed to the touch and handling by the
experimenter and to the food reward in their home cage. In a
second step food was rationed so that mice were kept at 90–95%
of their free-feeding body weight, which was controlled by daily
measurement. On the last 2 days of the habituation period, mice
were habituated to the T-maze by letting them explore the maze
and find the food rewards first without any arm being closed
and then with one arm being closed. This was performed four
times for each mouse, with intervals of 10min. On testing days,
animals were transferred into the testing room 5–10min before
testing in order to achieve an optimal state of arousal. On five
consecutive days each mouse was subjected to 10 trial runs. For
each trial run sample and choice arm were chosen randomly and
both arms were baited with a reward. Then a door blocked the
choice arm and the mouse was transferred into the start area
in order to allow them to explore the sample arm and consume
the reward. Immediately afterwards the mouse was placed into
the start area again, facing away from the arms, and the door
of the choice arm was removed so that the mouse could enter
both arms. If the mouse directly entered into the choice arm
the trial was recorded as correct choice, if it entered the sample
arm again the trial was counted as wrong choice. Mice were
also tested in the spontaneous alternation paradigm. For this
paradigm no habituation was performed, as it is based on the
novelty of the maze and the explorative drive of rodents. For
each mouse one trial was performed. The mouse was placed
into the start area with both arms open and was allowed to
choose a goal arm. This arm was gently closed behind the mouse.
After 30 s the mouse was removed, the goal arm was opened
again and the mouse was placed into the start area facing away
from the arms. Again it was allowed to choose between the two
open arms.
Weight Analysis
For the analysis of body weight, mice were weighed weekly
starting after weaning until they reached an age of 30 weeks.
Home Cage Activity
Mice were monitored in their home cages using the Infra-Mot
system (TSE, Bad Homburg, Germany) for three dark and two
light phases to record their basal activity and circadian rhythm.
Barnes Maze
A white circular arena (96 cm diameter) without walls with 20
circular holes (3.5 cm diameter) that were equally distributed
around the perimeter was set up at a height of 120 cm. The escape
box made out of black plastic could be positioned under any of
the holes. The remaining holes could be closed by small lids. The
maze was placed in the center of the testing room, illuminated
to 60 lx and four spatial cues were positioned around the maze.
Mice were transferred into the anteroom of the testing room 24 h
before habituation to the maze. For each mouse included in the
experiment, a different target hole was chosen and remained the
same throughout the entire experiment. During habituation each
mouse was placed onto the maze for 5min to explore the maze
and find both the target hole and escape box for the first time. In
case it did not find the target hole, the experimenter gently guided
it there. After that, themouse was habituated to the escape box for
2min. The habituation day was followed by 4 days of acquisition
(day 1–day 4), each consisting of 3 trials. During the trials, each
mouse was placed onto the maze for 3min and given the chance
to explore the maze and find the target hole with the escape box.
The trials were monitored using the Video-Mot 2 equipment and
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software (TSE-systems, Bad Homburg, Germany). The number
of primary errors (visits to wrong holes before finding the target
hole), the primary latency (time until reaching the target hole)
and the primary path length (path traveled until reaching the
target hole) were analyzed. On days 5 and 12 probe trials were
performed to test short and long-term memory. The target hole
was closed, the mouse was placed onto the maze for 5min and
later the maze was divided into four quadrants and the time spent
in each quadrant was analyzed. The target hole was always in the
center of quadrant 1.
Open Field, Elevated Plus Maze, and Light-Dark Test
The open field, elevated plus maze and light-dark tests were
performed as previously published (Wittmann et al., 2008)
and in accordance with the recommendations of EMPRESS
(European Mouse Phenotyping Resource of Standardized
Screens; http://empress.har.mrc.ac.uk). Twenty four hour before
the beginning of experiments mice were transferred to the
anteroom of the testing room. Free access to food and water
and the light-dark cycle were maintained. All tests were video
monitored using the Video-Mot 2 equipment and software (TSE-
systems, Bad Homburg, Germany). Mice were subjected to the
tests in the following order: open field, elevated plus maze and
light-dark test. Between the tests there were 3 test free days
each. Open field arenas consisted of a size of 50 × 50 cm, were
illuminated to 150 lx and subdivided into three zones: border
zone (8 cm along the walls), intermediate zone and central zone
(central 16% of overall arena). Exploratory activity was observed
for 10min. The elevated plus maze with two enclosed arms (20
cmwalls) and two open arms, each 50× 5 cm in size, was elevated
about 80 cm above ground. Exploratory activity wasmonitored in
the open arms for 5min at 180 lx. Finally, the light-dark test was
performed in the same arenas as the open field with a black box
covering 1/3 of the area and exploratory activity was monitored
for 10min at 400 lx.
Electrophysiology
Preparation of Acute Hippocampal Slices
Transversal hippocampal slices were prepared as described
previously (Bischofberger et al., 2006). Mice of a minimum
age of 4 weeks were chosen to ensure completed hippocampal
development. Mice were anesthetized with Isoflurane (Forane R©)
and decapitated using scissors. Brains were quickly removed
and placed into ice cold sucrose-based cutting/storage solution
containing (inmM): sucrose 75, glucose 10, NaCl 87, NaHCO3
25, NaH2PO4 1.25, KCl 2.5, MgCl2 7, and CaCl2 0.5, equilibrated
with 95% O2 and 5% CO2, osmolarity: ∼320 mOsm, pH 7.4.
The two hemispheres were cut at the midsagittal line, placed
with the sagittal plane facing down and a cut tangential to the
dorsal surface and perpendicular to the sagittal plane, was used
to cut away the dorsal part of the brain to conserve the integrity
of the mossy fiber tract (Bischofberger et al., 2006). Transversal
slices (300µm thick) were prepared using a vibratome (VT
1200S, Leica Microsystems). Slices were kept at ∼34◦C for
30min and thereafter at room temperature (RT) in sucrose-based
cutting/storage solution.
Patch-Clamp Recordings
Slices were transferred to a recording chamber mounted on a
Zeiss Axioskop 2 FSmot and continuously perfused with artificial
cerebrospinal fluid (aCSF) containing (in mM): glucose 25, NaCl
125, NaHCO3 25, NaH2PO4 1.25, KCl 2.50, MgCl2 1, CaCl2 2,
equilibrated with 95% O2 and 5% CO2, osmolarity:∼320 mOsm,
pH 7.4, flow rate: 2–3 ml/min. Patch pipettes were filled with
intracellular solution containing (in mM): K+-gluconate 135,
KCl 20, EGTA 0.1, MgCl2 2, Hepes 10, NaGTP 0.3, MgATP
2, osmolarity: ∼295 mOsm, pH 7.3. Pipette resistance was 4–
5 M after filling. For data aquisition EPC10 amplifier and
software (PATCHMASTER, HEKA Elektronik, Lambrecht/Pfalz,
Germany) were used. Experiments were performed at room
temperature and the amplifier software automatically corrected
the junction potential, which was 23.72 ± 0.52mV. Data
were filtered using a Bessel filter at 2.9 kHz and the sampling
rate ranged from 4 to 50 kHz depending on the protocol
applied. CA3 pyramidal neurons were maintained at −70mV
holding potential in the whole cell voltage clamp configuration
of the patch-clamp technique and at 0 pA in current clamp
configuration. At the beginning of every recording, passive
membrane properties (series resistance, capacitance and input
resistance) were determined using a block pulse protocol of
+10mV and 30 ms. Series resistance was between 12 and 30 M
and not routinely compensated. For recordings in the voltage
clamp configuration, series resistance was monitored regularly
throughout the experiment. For current clamp recordings, series
resistance was monitored at the beginning and at the end of
the experiment. Duration of the recordings was up to 45min
and series resistance change over time usually was about 10%.
The resting membrane potential (RMP) was determined in
current clamp mode, and recordings were discarded if RMP was
above −50 mV or if cells displayed spontaneous action potential
firing.
Assessment of Basic Electrophysiological Properties
In order to determine rheobase and action potential (AP)
parameters depolarizing current steps (30 pA increase, 500
ms duration) starting at −240 pA were applied. AP analysis
was performed as follows and as it has been described
previously (Sørensen et al., 2011; Langeslag et al., 2014).
The first three evoked action potentials were averaged. To
achieve this, trace fit functions within the FITMASTER software
(HEKA Elektronic, Lambrecht/Pfalz, Germany) and Microsoft
Excel for further mathematical calculations were used. AP
overshoot, afterhyperpolarization (AHP) and the AHP time
constant (τAHP) were measured. AP threshold and the speed
of both depolarization and repolarization were derived from
the 1st derivative of the AP. For AP duration, the half-
amplitude was calculated and duration at this value was
measured. Two ramp-shaped current stimuli (5 s duration)
based on 1x rheobase and 2x rheobase were applied to
analyze the number of action potentials and the duration of
interspike intervals. For current—frequency analysis frequency
was defined as 1/interspike interval and plotted against the
relative current intensity from 0 to 200% of rheobase. In
order to test the influence of S1P, RMP was recorded for
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10min under control conditions (aCSF) followed by 10min
application of S1P (1 µM). Following this chemical stimulus, the
step- and the ramp-shaped current stimulation protocols were
repeated.
Evoked Excitatory Postsynaptic Currents (eEPSCs)
For the recording of eEPSCs a bipolar tungsten stimulation
electrode was placed in the granule cell layer/hilus and constant-
current pulses (width 0.1 ms, 0.05 Hz) were applied. To
pharmacologically isolate non-NMDA receptor mediated EPSCs
the GABAA receptor antagonist picrotoxin (100 µM) and the
NMDA receptor antagonist D-APV (100 µM) were added to
the aCSF. eEPSCs were recorded in voltage clamp mode for
10 min, followed by 10min with additional application of
S1P (1 µM) and another 10min under control conditions.
eEPSC amplitudes were normalized to the mean eEPSC
amplitude during the first 10min of the recording. For the
analysis of 10–90% rise and decay times, the rise time
function within the trace fit functions of FITMASTER was
used.
Statistical Analysis
For detailed statistical analysis GraphPad Prism 5 (GraphPad
Software, Inc.) was used. Data are presented as mean ±
SEM. Box plots extend from 25 to 75th percentile and
display median (line), mean (cross) and whiskers (Tukey
method). Scatter dot plots present individual data points
and median with interquartile range. Two-way repeated
measures ANOVA followed by Bonferroni post hoc tests,
two-way ANOVA followed by Bonferroni post hoc test and
Mann-Whitney U-test for comparisons between groups were
used. Differences were considered statistically significant at
p< 0.05.
RESULTS
S1P3 is expressed in the central nervous system both in rodents
and humans (Yamaguchi et al., 1996; Zhang et al., 1999)
including the hippocampus, whose function is required for task
learning in the rewarded alternation T-maze test (Deacon et al.,
2002; Deacon and Rawlins, 2006). Therefore, we investigated
the expression of S1P3 in hippocampi of WT and S1P
−/−
3
mice. To assess location and expression pattern of S1p3-
mRNA in mouse hippocampus, in-situ hybridization was used
since indirect immunofluorescence did not provide unequivocal
results due to the lack of selective antibodies. Expression of
S1p3 mRNA was present predominantly in the pyramidal cell
layer and the staining pattern supported expression in neurons
throughout the hippocampal formation (Figures 1A–C). qRT-
PCR measurements, clearly demonstrated the expression of S1p3
mRNA in hippocampi from WT mice, whereas no expression of
S1p3 mRNA was detectable in hippocampi from S1P
−/−
3 mice
(Figure 1D). No significant compensatory change in expression
levels were detected of the other four S1P receptors in S1P
−/−
3
mice (Table 1).
FIGURE 1 | S1P
−/−
3
mice displayed working memory deficit and no
expression of S1p3 mRNA in hippocampal principal cells. (A–C) In situ
hybridization of mouse hippocampus. (A) In situ hybridization for the S1P3
receptor subtype in mouse hippocampus showed strong staining of the areas
CA1–CA3 as well as the dentate gyrus. Bar = 400 mm (B) Higher
magnification shows intense perinuclear staining at the border between CA3
and dentate gyrus. Bar = 200 mm (C) Incubation with a DIG-labeled
scrambled probe gave no signal. Bar = 200 mm. (D) S1p3 mRNA was
expressed in hippocampi from WT mice while S1P
−/−
3 mice showed no
hippocampal expression of S1p3 mRNA (Mann-Whitney U-test: **p < 0.01, n
= 6). (E) S1P
−/−
3 mice showed significant impairment in the T-maze rewarded
alternation spatial working memory task when compared to WT control mice
(two-way repeated measures ANOVA with Bonferroni post-tests: *p < 0.05,
**p < 0.01, n = 8).
TABLE 1 | Expression levels of S1P receptors 1, 2, 4, and 5 in hippocampi
from WT and S1P
−/−
3
mice.
Gene name WT S1P
−/−
3
p-value
S1pr1 1 ± 0.037404 1.097586 ± 0.178521 0.6286
S1pr2 1 ± 0.091626 1.057782 ± 0.094352 0.8286
S1pr4 1 ± 0.0066300 1.353522 ± 0.206668 0.4857
S1pr5 1 ± 0.150916 1.367538 ± 0.114230 0.2000
Data are presented as mean ± SEM (Mann-Whitney U-test; n = 4)
Function of S1P Receptor 3 in Formation of
Working Memory
We applied a panel of behavioral experiments including
basic observations of weight development, circadian rhythm,
memory related tests (T-maze, Barnes maze) and several
anxiety related tests (open field, elevated plus maze, light-
dark test). As previously published by other groups, mice
lacking the S1P3 receptor did not show any obvious phenotypic
abnormalities when compared to WT littermates, that is they
were indistinguishable from their WT littermates and displayed
a comparable overall health, fertility and longevity (Ishii, 2001;
Kono et al., 2004).
In order to specifically assess the function of S1P3 in memory
formation and retrieval, we performed a T-maze test using
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FIGURE 2 | S1P
−/−
3 mice displayed no deficits in further behavioral assessment. (A–C) Barnes maze test of S1P
−/−
3 and WT mice. (A) S1P
−/−
3 mice neither
differed significantly from WT mice in the Barnes maze spatial reference memory task during the training period (two-way repeated measures ANOVA: n.s., WT: n = 6,
S1P
−/−
3 : n = 10) nor in the (B) short-term memory test on day 5 (two-way repeated measures ANOVA: n.s., WT: n = 6, S1P
−/−
3 : n = 10) or in the (C) long-term
memory test on day 12 (two-way repeated measures ANOVA: n.s., WT: n = 6, S1P
−/−
3 : n = 10). (D) S1P
−/−
3 mice spent a similar amount of time in the open area
during the light-dark test (Mann-Whitney U-test: n.s., WT: n = 8, S1P
−/−
3 : n = 9). (E) S1P
−/−
3 mice spent similar amounts of time in the different zones of the open
field test as WT control mice (two-way ANOVA: n.s., WT: n = 8, S1P
−/−
3 : n = 9). (F) S1P
−/−
3 mice spent similar amounts of time on the open and closed arms of the
elevated plus maze (two-way ANOVA: n.s., WT: n = 8, S1P
−/−
3 : n = 9). (G) S1P
−/−
3 and WT littermates showed similar weight gain over a course of 30 weeks after
birth (two-way repeated measures ANOVA: n.s., WT: n = 5, S1P
−/−
3 : n = 10). (H) S1P
−/−
3 and WT mice displayed similar circadian rhythm in a home cage activity
test (two-way repeated measures ANOVA: n.s., n = 4).
the rewarded alternation paradigm, a simple and sensitive
test based on an appetitive motivation in rodents to discover
cognitive dysfunction (Deacon and Rawlins, 2006). During
a course of 5 trial days WT mice displayed normal task
learning, whereas S1P
−/−
3 mice displayed a significant learning
impairment (correct choice: trial day 1: WT: 61.3 ± 5.2%,
S1P
−/−
3 : 50.0 ± 7.6%; trial day 5: WT: 80.0 ± 5.0%, S1P
−/−
3 :
43.8 ± 10.2%; p < 0.05; two-way repeated measures ANOVA,
Figure 1E). Using the spontaneous alternation paradigm, which
tests whether the novelty of the maze leads to spontaneous
exploration and alternation of choice arms or whether mice
display a side preference, S1P
−/−
3 and WT mice demonstrated
comparable normal choice alternation rates of 75% (n= 8).
In contrast to their performance deficit in the T-maze
test, S1P
−/−
3 mice showed no significant differences in the
spatial reference memory Barnes maze test, neither during the
acquisition phase on days 1–4 nor during the probe trials on days
5 and 12 (primary errors: day 1:WT: 19. 83± 3.49, S1P
−/−
3 : 15.83
± 2.25; day 4: WT: 4.72 ± 2.01, S1P
−/−
3 : 3.33 ± 2.37; two-way
repeated measures ANOVA: n.s.; time spent in quadrant 1: day 5:
WT: 49.29 ± 10.85%, S1P
−/−
3 : 46.29 ± 5.16%; day 12: WT: 42.62
± 7.04%, S1P
−/−
3 : 39.84 ± 4.37%; two-way repeated measures
ANOVA: n.s.; Figures 2A–C). Furthermore, no differences could
be seen when comparing the primary latency and the primary
path length during the acquisition phase (primary latency: day 1:
WT: 145.06± 16.96 s, S1P
−/−
3 : 152.03± 10.11 s; day 4:WT: 16.36
± 2.99 s, S1P
−/−
3 : 22.33 ± 11.00 s; two-way repeated measures
ANOVA: n.s.; primary path length: day 1: WT: 779.97 ± 94.56
cm, S1P
−/−
3 : 762.97 ± 95.22 cm; day 4: WT: 150.30 ± 34.28
cm, S1P
−/−
3 : 151.58 ± 64.52 cm; two-way repeated measures
ANOVA: n.s.).
In a series of anxiety related tests, no significant differences
were observed (Figures 2D–F). In the light-dark test S1P
−/−
3
mice spent similar amounts of time in the light compartment
(light area time: WT: 220.5 ± 17.80 s, S1P
−/−
3 : 250.6 ± 38.76 s;
Mann-Whitney U-test: n.s.; Figure 2D) as well as in the three
different zones in the open field test (border zone: WT: 436.65 ±
34.05 s, S1P
−/−
3 : 441.50± 18.43 s; intermediate zone: WT: 110.77
± 17.64 s, S1P
−/−
3 : 114.14 ± 16.03 s; central zone: WT: 52.53
± 17.24 s, S1P
−/−
3 : 44.31 ± 7.04 s; two-way repeated measures
ANOVA: n.s.; Figure 2E). Furthermore, S1P
−/−
3 mice showed
normal behavior in the elevated plus maze (open arm: WT: 9.19
± 2.68 s, S1P
−/−
3 : 6.13± 2.55 s; closed arm:WT: 231.82± 10.67 s,
S1P
−/−
3 : 252.74± 7.03 s; two-way ANOVA: n.s.; Figure 2F).
S1P
−/−
3 , S1P
+/−
3 and WT littermates also displayed similar
weight development (week 4: WT: 13.57 ± 1.11 g, S1P
+/−
3 :
15.05 ± 0.72 g, S1P
−/−
3 : 17.28 ± 0.59 g; week 30: WT: 37.38 ±
1.18 g, S1P
+/−
3 : 35.66 ± 1.33 g, S1P
−/−
3 : 35.89 ± 0.97 g; two-
way repeated measures ANOVA: n.s.; Figure 2G), also circadian
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TABLE 2 | Basic electrophysiological properties of principal neurons in
area CA3 in acute hippocampal slices from WT and S1P
−/−
3
mice.
CA3 WT (n = 21) S1P
−/−
3 (n = 21) p-value
Series resistance [M] 19.6±0.8 21.6±0.8 0.0994
Capacitance [pF] 137.9±6.5 123.2±62 0.0741
Input resistance [M] 331.2±21.6 251.3±16.8 0.0048**
Resting membrane
potential [mV]
−66.1±1.4 −65.2±1.5 0.6689
Rheobase [pA] 125.7±11.1 150.0±19.5 0.4256
AP no. in ramp based on
1x rheobase
10.2±1.5 7.5±1.0 0.2714
Interspike intervals [ms] 167.2±14.1 268.1±58.8 0.0536
AP no. in ramp based on
2x rheobase
23.8±1.6 18.8±2.3 0.0659
Interspike intervals [ms] 105.3±15.7 235.1±46.7 0.0021**
AP threshold [mV] −37.3±1.0 −39.2±1.0 0.2085
AP overshoot [mV] 57.7±0.6 56.8±1.2 0.9298
AP afterhyperpolarization
[mV]
−50.0±0.7 −50.7±0.6 0.2794
τAHP [ms] 3.1±0.48 3.3±0.36 0.3024
AP amplitude [mV] 94.9±1.5 96.0±1.8 0.5294
AP duration [ms] 1.1±0.08 1.1±0.06 0.2905
Depolarization speed
[mV/ms]
449.4±26.5 414.3±25.5 0.3651
Repolarization speed
[mV/ms]
−74.3±3.9 −70.6±3.2 0.4812
Data are presented as mean± SEM (Mann-Whitney U-test: **p< 0.01). No correction for
multiple comparisons has been performed. Bold values are statistically significant values.
rhythms did not differ between S1P
−/−
3 and WT mice (two-way
repeated measures ANOVA: n.s.; Figure 2H).
Together these results are suggesting a specific role of S1P3
receptor for appetitively motivated memory formation in the
hippocampus.
Alteration of General Electrophysiological
Properties in S1P Receptor 3 Depleted
Neurons
Since we observed significant differences between the two
genotypes within the hippocampal based T-maze test, we
explored basic electrophysiological properties of hippocampal
principal neurons in situ using whole cell patch clamp
recordings on acute hippocampal slices. We concentrated on
hippocampal area CA3 as it was demonstrated previously
that S1P3 translocates to presynaptic nerve terminals upon
stimulation with S1P in acutely dissociated CA3 pyramidal
neurons (Kanno et al., 2010), suggesting a specific role of
this receptor in CA3 but not in CA1 neurons. The following
parameters were investigated: series resistance, capacitance,
input resistance, rheobase, AP threshold, AP overshoot, AP
afterhyperpolarization, τAHP, AP amplitude, AP half duration,
AP depolarization and repolarization speed, AP frequency and
AP interspike interval (see Table 2). Neurons with a deficiency
of S1P3 exhibited significantly longer and less regular interspike
FIGURE 3 | Principal neurons in hippocampal area CA3 of S1P
−/−
3 mice
displayed higher interspike intervals and a lower input resistance the
WT control neurons. (A) Representative traces of whole cell current clamp
recordings of principal neurons in area CA3 of acute hippocampal slices from
WT and S1P
−/−
3 mice during ramp based on 2x rheobase. S1P
−/−
3 neurons
showed significant higher interspike intervals. (B) Quantification of recordings
represented in (A) (Mann-Whitney U-test: **p < 0.01, n = 21). (C)
Current—frequency (I-f) relationship. Frequency increases with current intensity
with a significantly stronger increase in WT neurons. (two-way ANOVA:
interaction p = 0.0002, genotype p < 0.0001, current intensity p < 0.0001,
Bonferroni post-tests: *p < 0.05, ***p < 0.001, n = 21) (D) Principal neurons
in area CA3 of acute hippocampal slices from S1P
−/−
3 mice had a significant
lower input resistance than WT control neurons (Mann-Whitney U-test: **p <
0.01, n = 21).
intervals as compared to WT control neurons (WT: 105.3± 15.7
ms, S1P
−/−
3 : 235.1± 46.7 ms; Mann-WhitneyU-test: p= 0.0021;
Figures 3A,B). No differences within the other AP parameters
were detected (Table 2). When we compared the current—firing
frequency relationships, we observed that in both genotypes
firing frequency increases with increasing current intensity, but
the increase was significantly stronger inWT neurons (at current
intensity 200% of rheobase: WT: 12.44 ± 1.802 Hz, S1P
−/−
3 :
6.062 ± 1.132 Hz; two-way ANOVA: interaction: p = 0.0002,
genotype: p < 0.0001, current intensity p < 0.0001, Bonferroni
post-test: p < 0.001; Figure 3C). Furthermore, S1P
−/−
3 neurons
displayed a significantly decreased input resistance (WT: 331.2±
21.6 M, S1P
−/−
3 : 251.3 ± 16.8 M; Mann-Whitney U-test: p
= 0.0048; Figure 3D). Taken together these facts hinted toward a
decreased neuronal excitability, which could be due to a change in
potassium conductance and a possible deregulation of potassium
channel expression.
Based on a literature research on potassium channels
associated with S1P signaling (Takabe et al., 2008; Benamer
et al., 2009, 2011) and hippocampal expression of potassium
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TABLE 3 | Potassium channel mRNA expression levels in hippocampi from
WT and S1P
−/−
3
mice.
Gene name WT S1P
−/−
3 p-value
Kcnj3 1 ± 0.076595 1.101751 ± 0.031515 0.5281
Kcnj6 1 ± 0.104304 1.115369 ± 0.111236 0.5714
Kcnj8 1 ± 0.041285 0.980659 ± 0.09296 0.5714
Kcnj9 1 ± 0.070697 1.073008 ± 0.074166 0.3867
Kcna4 1 ± 0.102338 0.919057 ± 0.155438 > 0.9999
Kcnc3 1 ± 0.125807 1.192529 ± 0.102352 0.2389
Kcnc4 1 ± 0.072289 1.063664 ± 0.055906 0.4285
Kcnd2 1 ± 0.109368 1.097379 ± 0.089368 0.6753
Kcnd3 1 ± 0.134945 0.985784 ± 0.119652 > 0.9999
Data are presented as mean ± SEM (Mann-Whitney U-test; n = 6–10).
channel α subunits as published in the Allen Mouse Brain
Atlas [(Lein et al., 2006), Website: © 2015 Allen Institute for
Brain Science. Allen Mouse Brain Atlas [Internet]. Available
from: http://mouse.brain-map.org], we selected nine potassium
channel candidates (Kcnj3, Kcnj6, Kcnj8, Kcnj9, Kcna4, Kcnc3,
Kcnc4, Kcnd2, Kcnd3) for mRNA quantification in hippocampi
of WT and S1P
−/−
3 mice. None of the potassium channels tested
displayed a significant deregulation in S1P
−/−
3 mice (Table 3).
S1P Modulated Electrophysiological
Properties of Principal Neurons in
Hippocampal Area CA3
Since S1P is the main ligand for the S1P receptors, we also
tested the effect of S1P application on basic electrophysiological
properties in CA3 principal neurons. Both in WT neurons
and neurons lacking S1P3 the resting membrane potential
hyperpolarized, with a slightly weaker effect in S1P
−/−
3 neurons
(RMP: WT control: −66.69 ± 1.66mV, WT with S1P: −72.17
± 1.43mV, S1P
−/−
3 control: −6450 ± 3.01mV, S1P
−/−
3 with
S1P: −68.17 ± 2.27mV; two-way repeated measures ANOVA:
treatment p < 0.0001, genotype p = 0.2904, interaction p =
0.2694, Bonferroni post-tests: WT p < 0.001, S1P
−/−
3 p <
0.05, Figures 4A,C). S1P treatment effects were observed in cell
capacitance, as it increased significantly in S1P
−/−
3 neurons, in
the τAHP, which decreased significantly in WT neurons, and
in depolarization speed, which increased significantly in WT
neurons (Table 4).
Additionally, we tested whether S1P application has an
influence on eEPSC amplitude, as reported previously (Kanno
et al., 2010). S1P application increased eEPSC amplitudes and
the effect was observed both inWT neurons and neurons lacking
S1P3, with a slightly weaker effect in S1P
−/−
3 neurons (relative
eEPSC amplitude with S1P: WT: 1.94 ± 0.34%, S1P
−/−
3 : 1.82
± 0.34%; two-way repeated measures ANOVA: treatment p =
0.0018, genotype: p= 0.9667, interaction: p= 0.9012, Bonferroni
post-tests: WT p < 0.01, S1P
−/−
3 p < 0.05, Figures 4B,D). We
further analyzed eEPSC kinetics, comparing 10–90% rise and
decay times. No significant differences in rise time were detected
FIGURE 4 | Application of S1P led to decrease in resting membrane
potential and increase in eEPSC amplitude. (A) Whole cell current clamp
recordings of principal neurons in area CA3 of acute hippocampal slices from
WT and S1P
−/−
3 mice. Both genotypes reacted to application of S1P with a
significant reduction in resting membrane potential, with a slightly stronger
effect in WT neurons (two-way repeated measures ANOVA with Bonferroni
post-tests compared to control mean: *p < 0.05, #p < 0.01,
†
p < 0.001, WT:
n = 10, S1P
−/−
3 : n = 8). (B) Whole cell voltage clamp recordings of principal
neurons in area CA3 with mossy fiber stimulation. Inserts show representative
traces of eEPSCs recorded before and during S1P application. Application of
S1P led to significant increase in eEPSC amplitude in both genotypes with a
slightly stronger effect in WT neurons (two-way repeated measures ANOVA
with Bonferroni post-tests compared to control mean: *p <0.05, #p < 0.01,
†
p < 0.001, WT: n = 6, S1P
−/−
3 : n = 5). (C) Quantification of (A) (two-way
repeated measures ANOVA with Bonferroni post-tests: *p < 0.05,
†
p <
0.001). (D) Quantification of (B) (two-way repeated measures ANOVA with
Bonferroni post-tests: *p < 0.05, #p < 0.01).
(WT control: 4.192± 0.557 ms, WT with S1P: 4.277± 0.583ms,
S1P
−/−
3 control: 3.66 ± 0.409ms, S1P
−/−
3 with S1P: 3.465 ±
0.314ms; two-way repeated measures ANOVA: interaction: p =
0.4722, treatment: p = 0.3408, genotype: p = 0.6841, Bonferroni
post-tests: n.s.), whereas a significant increase of decay times after
S1P was observed (WT control: 21.42 ± 1.979 ms, WT with S1P:
24.08 ± 2.124 ms, S1P
−/−
3 control: 20.86 ± 2.513 ms, S1P
−/−
3
with S1P: 21.46 ± 2.05ms; two-way repeated measures ANOVA:
interaction: p = 0.0716, treatment: p = 0.0109, genotype: p =
0.6147, Bonferroni post-tests: WT: p< 0.05, S1P
−/−
3 : n.s.).
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TABLE 4 | Basic electrophysiological properties of principal neurons in area CA3 in acute hippocampal slices from WT and S1P
−/−
3
mice before and after
S1P application.
CA3 WT (n = 10) S1P
−/−
3
(n = 8) Two-way repeated measures ANOVA Bonferroni post-tests of S1P
treatment effects
before S1P after S1P before S1P after S1P Interaction
p-value
S1P treatment
effect
p-value
Genotype effect
p-value
WT
p-value
S1P
−/−
3
p-value
Series resistance [M] 22.20± 0.8 27.28±3.8 23.19± 0.9 24.18± 1.8 0.3118 0.141 0.6956 > 0.05 > 0.05
Capacitance [pF] 120.3± 5.5 131.0±7.5 126.1± 9.1 149.4± 13.3 0.0855 < 0.0001*** 0.3291 > 0.05 < 0.001***
Input resistance [M] 354.1± 33.6 347.9±40.4 257.0± 37.7 275.1± 39.7 0.5994 0.7966 0.1027 > 0.05 > 0.05
Resting membrane
potential [mV]
−66.7± 1.7 −70.6±1.4 −64.5± 3.0 −67.1± 2.3 0.2694 < 0.0001*** 0.2904 < 0.001*** < 0.05*
Rheobase [pA] 108.0± 10.2 108.0±9.2 120.0± 17.0 131.3± 12.6 0.3724 0.3724 0.2886 > 0.05 > 0.05
AP no. in ramp based on
1x rheobase
12.5± 2.4 7.9±2.0 7.3± 1.7 7.3± 1.3 0.0787 0.0787 0.2698 < 0.05* > 0.05
Interspike intervals [ms] 169.6± 29.8 278.9±37.2 365.2± 161.1 200.3± 28.3 0.0818 0.7101 0.4739 > 0.05 > 0.05
AP no. in ramp based on
2x rheobase
24.3± 2.6 19.5±2.8 19.25± 3.9 21.9± 3.2 0.0156 0.4396 0.7522 < 0.05* > 0.05
Interspike intervals [ms] 138.6± 27.9 150.0±23.4 301.6± 113.4 171.4± 30.9 0.1125 0.1780 0.1883 > 0.05 > 0.05
AP threshold [mV] −39.2± 1.2 −39.1±1.0 −37.9± 1.8 −37.5± 2.1 0.4984 0.4350 0.5066 > 0.05 > 0.05
AP overshoot [mV] 59.7± 0.4 60.5±0.7 59.1± 1.5 59.6± 1.6 0.6884 0.0695 0.6134 > 0.05 > 0.05
AP afterhyperpolarization
[mV]
−52.0± 1.0 −50.9±0.8 −50.0± 1.1 −49.5± 1.3 0.5119 0.0813 0.2339 > 0.05 > 0.05
τAHP [ms] 4.33± 0.84 3.58±0.65 3.89± 0.60 3.57± 0.72 0.2621 0.0108* 0.8241 < 0.05* > 0.05
AP amplitude [mV] 98.9± 1.5 99.6±1.4 97.0± 2.4 97.0± 2.3 0.3140 0.2914 0.4055 > 0.05 > 0.05
AP duration [ms] 1.37± 0.068 1.38±0.078 1.33± 0.085 1.31± 0.080 0.3878 0.7086 0.6441 > 0.05 > 0.05
Depolarization speed
[mV/ms]
376.7± 24.9 414.7±28.6 396.9± 44.0 406.3± 37.7 0.0560 0.0036** 0.9013 < 0.01** > 0.05
Repolarization speed
[mV/ms]
−59.5± 2.4 −58.6±2.8 −59.4± 3.1 −59.6± 2.9 0.3914 0.6010 0.9163 > 0.05 > 0.05
Data are presented as mean ± SEM (Two-way repeated measures ANOVA with Bonferroni post-tests: * p < 0.05, ** p < 0.01, *** p < 0.001).
These results suggest that S1P3 receptor may contribute to
modulation of neuronal excitability and synaptic transmission
by S1P, but since no significant interaction between genotype
and S1P treatment was detected, it is likely that the other S1P
receptors contribute to the observed S1P treatment effects.
DISCUSSION
In this study, we provide evidence that the S1P3 receptor is
associated with a distinct role in hippocampal function both
in vivo and in vitro. Mice lacking S1P3 showed a significant
impairment in an appetitivelymotivated spatial workingmemory
task, but no impairments in other behavioral tests. The transgenic
mouse model used in the present study suggests that S1P
modulation of EPSCs does not require the presence of S1P3
receptors. However, principal neurons in hippocampal area CA3
lacking S1P3 exhibited significantly increased interspike intervals
and significantly decreased input resistance, pinpointing to a
critical role of the S1P3 receptor for the regulation of neuronal
excitability in general.
Not only S1P3, but also S1P receptors 1, 2, 4, and 5 are
expressed, with varying expression levels, in the different cell
types of the central nervous system (for review see Choi and
Chun, 2013) where they have been connected to various cellular
functions including synaptic transmission (Soliven et al., 2011).
In this study, we demonstrate that depletion of S1P3 does not lead
to a significant change in mRNA expression levels of the other
receptors. Since all other receptors are expressed, it is very likely
that they are able to compensate for the loss of S1P3 as they can
activate the same downstream signaling pathways.
Depletion of the S1P producing enzyme SphK1 with reduced
S1P production induces an impairment of mossy fiber—CA3
LTP and a significant deficit in spatial reference memory (Kanno
et al., 2010). In contrast, mice with a depletion of SphK2 display
lower levels of hippocampal S1P, reduced histone acetylation and
deficits in spatial memory as well as impaired contextual fear
extinction (Hait et al., 2014). Thus, S1P and SphKs play specific
roles in brain areas serving specific memory functions through
intracellular S1P effects as well as signaling pathways downstream
of S1P GPCRs.
Mechanisms of memory formation are most extensively
studied in the hippocampus where SphK1 expression levels are
high exclusively within hippocampal mossy fibers (Kanno et al.,
2010) whereas Sphk2 and S1p2 mRNA are expressed in the CA1–
CA3 regions (Blondeau et al., 2007; Akahoshi et al., 2011; Kempf
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et al., 2014). Involvement of S1P1 in memory formation has not
yet been demonstrated and mice with a global depletion of S1P1
are embryonically lethal (Liu et al., 2000). Since S1P1 expression
is restricted to astrocytes and endothelial cells it is likely that this
particular S1P receptor subtype affects synaptic plasticity since
via indirect mechanism as astrocytes have been shown to regulate
synaptic transmission and neuronal excitability (Volterra and
Meldolesi, 2005; Brana et al., 2014).
S1P
−/−
2 mice show signatures of augmented anxiety in the
open field test and display a spatial working memory deficit
in the eight arm radial maze, but no change in LTP formation
at Schaffer collateral—CA1 synapses (Akahoshi et al., 2011).
Interestingly though, inhibition of S1P2 leads to an increase in
Schaffer collateral—CA1 LTP and a similar effect is observed
when the newly discovered endogenous S1P2 ligand Nogo-
A is neutralized (Kempf et al., 2014). In addition, we now
demonstrate S1P3 expression in hippocampal neurons and this
has been associated with a working memory deficit which was
restricted to the performance of S1P
−/−
3 mice in an appetitively
motivated T-maze task but none of the other tests performed.
Mice displayed normal novelty and exploratory driven behavior
and normal reference memory function. A possible explanation
for the observed differences in behavior between the memory-
related tests may be offered by a reduced appetitive motivation
of S1P
−/−
3 mice. Another possibility could be a reduced capacity
to learn a working memory task, which might also be due to
changes in brain structures other than the hippocampus. Brain
structures involved in spatial memory tasks include the temporal
neocortex, basal forebrain, thalamus, prefrontal cortex, dorsal
striatum, vestibular system, and cerebellum, and for example
lesions of the entorhinal cortex lead to an impairment of learned
alternation in rats (Lalonde, 2002).
Kanno et al were able to show that S1P3 translocates to
presynaptic nerve terminals upon stimulation with S1P in acutely
dissociated CA3 pyramidal neurons and leads to glutamate
release at mossy fiber terminals (Kanno et al., 2010; Kanno and
Nishizaki, 2011). Pharmacological evidence suggests that S1P and
S1P3 are associated with LTP formation (Maggio et al., 2014).
However, S1P significantly increased eEPSC amplitudes and
eEPSC decay times both in WT and in S1P
−/−
3 mice, suggesting
an increase in glutamate release, and possibly a reduction in
non-NMDA receptor desensitization. Furthermore, S1P also
decreased the resting membrane potential in both genotypes,
leading to the conclusion that S1P3 shares redundant functions
with other S1P receptors within CA3 neurons converging onto
the same signaling pathways (Choi and Chun, 2013).
Although WT cells and cells lacking S1P3 were similar
in their responses to S1P, significant differences in basic
electrophysiological properties were detected. S1P
−/−
3 CA3
hippocampal principal neurons displayed significantly longer
interspike intervals and decreased input resistances, indicating a
general reduction of excitability, which might be the underlying
cause for the reduced performance of S1P
−/−
3 mice in the
working memory task of learned alternation in the T-maze.
We hypothesized that this reduced excitability might be
caused by an involvement of potassium channels. So far no direct
relationship between S1P signaling and potassium channels has
been demonstrated in central neurons, but few publications
from other areas of research link S1P receptors to several types
of potassium channels. For example, S1P activates inwardly
rectifying K+ currents (IK.ACh) in ventricular myocytes with the
involvement of S1P1 and S1P3 (Landeen et al., 2008) and the
SUR2/Kir6.2 channel via S1P3 in mouse ventricular fibroblasts
(Benamer et al., 2009, 2011). Although a direct regulatory
effect of S1P3 on potassium channel activity is not supported
by the present results, this leaves three alternative possibilities
as explanations for the significantly reduced input resistance
and firing frequency in S1P
−/−
3 mice: first, other members of
the large potassium channel family may be targeted by S1P3
receptor signaling similar to a study in human anaplastic thyroid
cancer cells where S1P down-regulates Kv11.1 regulation via
S1P2 (Asghar et al., 2012). Second, protein expression may be
deregulated by mechanisms independent of transcription e.g., by
microRNAs as shown for BK potassium channels (Pietrzykowski
et al., 2008) or third, posttranslational modifications of ion
channels such as protein phosphorylation or trafficking may be
affected by S1P3 receptor depletion (Johnston et al., 2010).
CONCLUSIONS
In the present study we provide evidence that the S1P3 receptor
plays a specific role in the context of learning and memory and in
a distinct subset of hippocampal principal neurons. S1P3 appears
important for the formation of spatial working memory in the
T-maze rewarded alternation paradigm through its influence on
neuronal excitability.
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